← Leaderboards
Nenad Bursac
Duke University
$22,509,345
Attributed
$30,293,329
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,293,329 · 18
By mechanism
R01$17,676,835 · 10
U01$10,359,035 · 3
R21$2,257,459 · 5
Top collaborators
- Timothy J Kamp7 shared
- Jianyi Zhang7 shared
- Dwight D Koeberl6 shared
- Charles A Gersbach4 shared
- George A Truskey4 shared
Most similar at Duke University
Same institution · by research overlap
- Michael A Hauser$15,968,846
- Dwight D Koeberl$10,403,079
- Nicholas A Strash$105,064
- Scott J Antonia$4,663,305
- Samuel Brandon Stephens$1,192,691
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsIn VitroEngineeringTissue EngineeringIn VivoFutureCardiacHeartImplantCardiac MyocytesStem CellsBasePropertyAdultOpticsHeart FailureMuscleMechanicsGenesMyocardiumRattusMyocardial Infarction3-Dimensional
Grant awards (64)
Engineering Human Heart Tissues with Polyploid Cardiomyocytes$548,968
R01 · FY2025 · HL · contact PI
Engineering Heterocellular Human Skeletal Muscle Tissues to Recreate and Study Native Stem Cell Niche Function$510,389
R01 · FY2025 · AR · contact PI
Engineering a Human Skeletal Muscle Tissue Model of LGMD2B$480,947
R01 · FY2025 · AR · contact PI
Engineered BacNav and BacCav for Improved Excitability and Contraction$477,473
R01 · FY2025 · EB · contact PI
Engineering Human Heart Tissues with Polyploid Cardiomyocytes$536,797
R01 · FY2024 · HL · contact PI
Engineering Heterocellular Human Skeletal Muscle Tissues to Recreate and Study Native Stem Cell Niche Function$526,174
R01 · FY2024 · AR · contact PI
Engineering a Human Skeletal Muscle Tissue Model of LGMD2B$501,861
R01 · FY2024 · AR · contact PI
Engineered BacNav and BacCav for Improved Excitability and Contraction$467,924
R01 · FY2024 · EB · contact PI
Engineering Human Heart Tissues with Polyploid Cardiomyocytes$544,566
R01 · FY2023 · HL · contact PI
Engineering a Human Skeletal Muscle Tissue Model of LGMD2B$525,946
R01 · FY2023 · AR · contact PI
Engineered BacNav and BacCav for Improved Excitability and Contraction$477,473
R01 · FY2023 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,164,534
U01 · FY2022 · HL
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2022 · HL
Engineering Human Heart Tissues with Polyploid Cardiomyocytes$541,410
R01 · FY2022 · HL · contact PI
Engineered BacNav and BacCav for Improved Excitability and Contraction$477,473
R01 · FY2022 · EB · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,168,782
U01 · FY2021 · HL
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2021 · HL
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,172,627
U01 · FY2020 · HL
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$656,092
U01 · FY2020 · HL
Muscle-macrophage constructs for skeletal muscle repair$384,780
R01 · FY2020 · AR · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,176,595
U01 · FY2019 · HL
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes$668,150
U01 · FY2019 · EB
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair$521,375
R01 · FY2019 · HL · contact PI
Engineering of Human Excitable Tissues from Unexcitable Cells$492,077
R01 · FY2019 · HL · contact PI
Muscle-macrophage constructs for skeletal muscle repair$384,780
R01 · FY2019 · AR · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$1,162,722
U01 · FY2018 · HL
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair$530,915
R01 · FY2018 · HL · contact PI
Engineering of Human Excitable Tissues from Unexcitable Cells$494,569
R01 · FY2018 · HL · contact PI
Muscle-macrophage constructs for skeletal muscle repair$384,780
R01 · FY2018 · AR · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$903,257
U01 · FY2017 · HL
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair$487,302
R01 · FY2017 · HL · contact PI
Engineering of Human Excitable Tissues from Unexcitable Cells$443,377
R01 · FY2017 · HL · contact PI
Muscle-macrophage constructs for skeletal muscle repair$384,780
R01 · FY2017 · AR · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$330,989
R01 · FY2017 · AR · contact PI
Integrated Cellular and Tissue Engineering for Ischemic Heart Disease$949,976
U01 · FY2016 · HL
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair$493,302
R01 · FY2016 · HL · contact PI
Engineering of Human Excitable Tissues from Unexcitable Cells$445,561
R01 · FY2016 · HL · contact PI
Muscle-macrophage constructs for skeletal muscle repair$384,780
R01 · FY2016 · AR · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$331,090
R01 · FY2016 · AR · contact PI
Bioengineering a Living Tissue Conductor$238,500
R21 · FY2016 · HL · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$331,188
R01 · FY2015 · AR · contact PI
Bioengineering a Living Tissue Conductor$198,750
R21 · FY2015 · HL · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$100,000
R01 · FY2015 · AR · contact PI
Function and Integration of Stem Cell-derived Cardiac Tissue Patch$372,572
R01 · FY2014 · HL · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$331,282
R01 · FY2014 · AR · contact PI
Function and Integration of Stem Cell-derived Cardiac Tissue Patch$362,144
R01 · FY2013 · HL · contact PI
Translational studies of GAA deficiency in bioengineered human muscle$331,372
R01 · FY2013 · AR · contact PI
Function and Integration of Stem Cell-derived Cardiac Tissue Patch$380,622
R01 · FY2012 · HL · contact PI
Engineering a Functional Skeletal Muscle$326,177
R01 · FY2012 · AR · contact PI
Tissue-engineered Autonomous Pacemaker$195,000
R21 · FY2012 · HL · contact PI
Function and Integration of Stem Cell-derived Cardiac Tissue Patch$370,679
R01 · FY2011 · HL · contact PI
Engineering a Functional Skeletal Muscle$326,177
R01 · FY2011 · AR · contact PI
Cardiac Progenitor Patch for Treatment of Myocardial Infarction$234,000
R21 · FY2011 · HL · contact PI
Tissue-engineered Autonomous Pacemaker$225,600
R21 · FY2011 · HL · contact PI
Function and Integration of Stem Cell-derived Cardiac Tissue Patch$348,484
R01 · FY2010 · HL · contact PI
Engineering a Functional Skeletal Muscle$339,768
R01 · FY2010 · AR · contact PI
Cardiac Progenitor Patch for Treatment of Myocardial Infarction$195,000
R21 · FY2010 · HL · contact PI
Engineering a Functional Skeletal Muscle$322,995
R01 · FY2009 · AR · contact PI
Engineered Cardiac Tissue with Controllable Architecture$133,600
R21 · FY2009 · HL · contact PI
Engineering a Functional Skeletal Muscle$321,517
R01 · FY2008 · AR · contact PI
Engineered Cardiac Tissue with Controllable Architecture$195,000
R21 · FY2008 · HL · contact PI
Engineered Cardiac Tissue with Controllable Architecture$228,400
R21 · FY2007 · HL · contact PI
Cellular Cardiomyoplasty in Vitro: Host-Donor Cell Interactions$189,295
R21 · FY2007 · HL · contact PI
Cardiomyoplasty in vitro: Host /Doner Cell Interactions$224,314
R21 · FY2006 · HL · contact PI